Tirzepatide (10 vials)

Tirzepatide is a dual GIP and GLP-1 receptor agonist extensively researched for its effects on metabolic regulation, glucose signaling, and energy balance. Its unique dual-action mechanism continues to be an important area of peptide research.

Tirzepatide, Tirzepatide Peptide, GLP-1, GIP Peptide, Research Peptide

Research-grade Tirzepatide peptide designed for laboratory studies involving GLP-1 and GIP receptor pathways.

Disclaimer: Our peptides are research-grade products for laboratory use only. They are not approved for human consumption or medical use. Always follow proper laboratory safety protocols.

Tirzepatide Research Peptide

Tirzepatide is a synthetic research peptide recognized for its dual incretin receptor activity. It is designed to activate both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, making it a valuable tool for studying the interconnected pathways involved in glucose metabolism, appetite regulation, and energy balance.

Metabolic and Endocrine Research

In laboratory research, Tirzepatide is commonly investigated for its effects on insulin signaling, glucose homeostasis, and metabolic function. Simultaneous activation of GIP and GLP-1 receptors allows researchers to evaluate how these pathways work together, providing insights into beta-cell activity, insulin sensitivity, and lipid metabolism that may not be observed with single-receptor agonists.

Appetite and Neuroendocrine Signaling

The peptide's extended activity profile makes it useful for examining long-term endocrine responses and metabolic feedback mechanisms. Research has focused on its role in appetite regulation, gastric emptying, satiety signaling, and the interaction between incretin hormones and central nervous system pathways involved in energy intake.

Lyophilized Research Format

This product is supplied as a 10 mg lyophilized (freeze-dried) powder to support stability during storage and handling. The freeze-dried format allows for accurate reconstitution and consistent preparation under appropriate laboratory conditions, making it suitable for dose-response experiments and extended research protocols.

Dual Incretin Mechanism

Unlike traditional GLP-1 receptor agonists, Tirzepatide targets both GIP and GLP-1 receptors. This dual mechanism has made it an important compound for researchers studying metabolic signaling, insulin secretion, adipose tissue biology, and nutrient utilization. Ongoing investigations continue to explore how combined receptor activation influences metabolic pathways compared with GLP-1 receptor activation alone.

Storage Recommendations

To maintain peptide stability, store the unreconstituted vial according to laboratory best practices. After reconstitution with an appropriate laboratory-grade solution, refrigerated storage between 2°C and 8°C is generally recommended to help preserve peptide integrity throughout the research period.

Research Applications

• Dual GIP and GLP-1 receptor agonist for laboratory research
• Studied in metabolic and endocrine signaling models
• Investigated in glucose regulation and insulin response pathways
• Used to examine appetite signaling, satiety, and energy balance
• Lyophilized powder for stability and consistent laboratory preparation
• Intended exclusively for qualified laboratory research use

Researchers frequently incorporate Tirzepatide into comparative metabolic studies to evaluate cellular energy utilization, endocrine signaling, and coordinated incretin receptor activity. Its dual-receptor profile continues to make it an important addition to peptide research programs investigating metabolic regulation and related biological processes.

Disclaimer: Tirzepatide is supplied exclusively for laboratory research purposes. It is not intended for human or veterinary use, medical treatment, diagnosis, or therapeutic application. All handling and use should comply with applicable laboratory regulations and institutional research standards.